Andrew R Marks (Andrew Marks)

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Chemotherapy Induced

Top Venues

Science advances

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yang Liu, Steven Reiken, Haikel Dridi, Qi Yuan, Khalid S Mohammad, Trupti Trivedi, Marco C Miotto, Kaylee Wedderburn-Pugh, Leah Sittenfeld, Ynez Kerley, Jill A Meyer, Jonathan S Peters, Scott C Persohn, Amanda A Bedwell, Lucas L Figueiredo, Sukanya Suresh, Yun She, Rajesh Kumar Soni, Paul R Territo, Andrew R Marks, Theresa A Guise
Targeting ryanodine receptor type 2 to mitigate chemotherapy-induced neurocognitive impairments in mice. Science translational medicine 15 (715) (2023)
Marco C Miotto, Gunnar Weninger, Haikel Dridi, Qi Yuan, Yang Liu, Anetta Wronska, Zephan Melville, Leah Sittenfeld, Steven Reiken, Andrew R Marks
Structural analyses of human ryanodine receptor type 2 channels reveal the mechanisms for sudden cardiac death and treatment. Science advances 8 (29) (2022)
Haikel Dridi, Frances Forrester, Alisa Umanskaya, Wenjun Xie, Steven Reiken, Alain Lacampagne, Andrew R Marks
Role of oxidation of excitation-contraction coupling machinery in age-dependent loss of muscle function in Caenorhabditis elegans . eLife 11 (2022)